Mathies and Crawford Named to Micronics Scientific Advisory Board.Health/Medical Writers BIOWIRE2K REDMOND, Wash.--(BW HealthWire)--May 17, 2001 Micronics, Inc. announced today two additions to its Scientific Advisory Board. Professor Richard A. Mathies of the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). -- Berkeley, will be joining the advisory board, bringing to it his significant experience in biotechnology and high throughput micro-chemical analysis. Professor Mathies received his B.S. Degree in Chemistry at the University of Washington. He earned the M.S. and Ph.D. Degrees in Physical Chemistry at Cornell University Cornell University, mainly at Ithaca, N.Y.; with land-grant, state, and private support; coeducational; chartered 1865, opened 1868. It was named for Ezra Cornell, who donated $500,000 and a tract of land. With the help of state senator Andrew D. and then was a Helen Hay Whitney Postdoctoral Fellow at Yale University Yale University, at New Haven, Conn.; coeducational. Chartered as a collegiate school for men in 1701 largely as a result of the efforts of James Pierpont, it opened at Killingworth (now Clinton) in 1702, moved (1707) to Saybrook (now Old Saybrook), and in 1716 was . He joined the Chemistry Department at the University of California at Berkeley (body, education) University of California at Berkeley - (UCB) See also Berzerkley, BSD. http://berkeley.edu/. Note to British and Commonwealth readers: that's /berk'lee/, not /bark'lee/ as in British Received Pronunciation. in 1976 where he is now Professor of Chemistry. His research areas include pioneering work in the development of microfabricated capillary electrophoresis devices, capillary array electrophoresis microplates, and microfabricated integrated sample preparation and detection methods. He is the author of over 250 publications and 20 patents in the fields of photochemistry photochemistry, study of chemical processes that are accompanied by or catalyzed by the emission or absorption of visible light or ultraviolet radiation. A molecule in its ground (unexcited) state can absorb a quantum of light energy, or photon, and go to a , bioanalytical chemistry and genome analysis technology. Joining Dr. Mathies as a new addition to Micronics' Scientific Advisory Board is Dr. Mark S. Crawford. Dr. Crawford received his Ph.D. from the University of Iowa Not to be confused with Iowa State University. The first faculty offered instruction at the University in March 1855 to students in the Old Mechanics Building, situated where Seashore Hall is now. In September 1855, the student body numbered 124, of which, 41 were women. and has done postdoctoral research at the University of Colorado University of Colorado may refer to:
tr.v. min·i·a·tur·ized, min·i·a·tur·iz·ing, min·i·a·tur·iz·es To plan or make on a greatly reduced scale. min . Since 1998 he has been President of Cerep, Inc., the US subsidiary of CerepSA. Cerep provides integrated drug discovery technologies through combinatorial chemistry, high throughput screening, and additional rapid compound characterization technologies. Dr. Crawford is on the Editorial Board of the Journal for Biomolecular Screening. Dr. Thomas Schulte, VP of R&D and Chief Technical Officer of Micronics said, "We are delighted to attract Professor Mathies and Dr. Crawford as members of Micronics' Scientific Advisory Board. Their exceptional experience in genomics, proteomics, and drug screening will provide guidance for Micronics as we expand the application of our proprietary microfluidic technologies to those very important business areas." About Micronics, Inc. Based in Redmond, Wash., Micronics is a leading developer of Microfluidics-based solutions for application in life science (genomics), in-vitro medical diagnostics and analytical chemistry markets. Micronics' proprietary technologies expand the boundaries of miniaturization in microfluidics, enabling companies to perform chemical reactions faster, less expensively and with less complexity. With 20 United States patents issued and over 40 pending applications in fundamental areas of microfluidics, Micronics is a leader in sample preparation, chemical separation and analysis, miniaturized cellular analysis and the analysis of whole blood and other complex fluids. Micronics partners with market leaders in fields where its technology can provide tangible commercial impact in the miniaturization of chemistry-based processes. Additional information is available at the Company's website, www.micronics.net. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion